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1. Introduction 
Two important molecules associated with neuro- 
muscular tr~smissiotl, acetylcholine receptor (ACHR) 
and acetylcholinesterase (ACHE, EC 3.1 .1.7) are 
present in chick embryo muscle cells in culture [I ,2]. 
Experiments have shown that muscle activity, acetyl- 
choline analogs, and me~nbrane-active drugs can alter 
levels of ACHE and ACHR [3-S]. One possible 
explanation for these effects is that ion balance 
regulates growth and differentiation of embryo muscle. 
The experiments reported here show that ouabain 
(strophanthin G), a specific inhibitor of Na’/K’ 
ATPase [6] increases ACHR levels, ACHE activity 
and RNA synthesis in cultured muscle cells. 
2. Methods 
2.1. Muscle cuEtures 
Primary cultures were prepared by dissociating 
day 11 chick embryo pectoral muscle with 0.1% 
trypsin and, after preplating, inoculating.them onto 
35 mm collagen-coated dishes at 5 X 10’ cells/dish 
in a medium of 88% (v/v) Eagles Minimal Essential 
Media (MEM) with Earles salts, 10% horse serum and 
2% chick embryo extract. Horse serum and embryo 
extract were treated in advance with IO-’ M and 
1 Ow7 M diisopropyl phosphofluoridate (DFP), res- 
pectively, to reduce cholinesterase levels by -85% in 
horse serum and 99% in embryo extract. Media were 
changed 72 h after inoculation and every 2 days 
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thereafter. Cultures were maintained at 37°C and 
pH 7.2-7.5 in an atmosphere of humidified air and 
regulated COa. 
2.2. A CHR assay 
Purified a-bungarotoxin, 200 pg (a gift from 
Dr M. Hanley , Chemical Biodynamics Lab., UC 
Berkeley) was iodinated by the iodine monochloride 
method (I]. The monoiodo derivative was isolated by 
ion-exchange chromatography on CM-52 cellulose as 
in [7]. The specific activity of the mono-[‘251]iodo- 
~-bungarotoxin ( ‘251-Cr-Bgt) was 2 X IO5 Cilmol. 
The number of ACHR molecules on the surface 
of the muscle fibers was determined using a modifica- 
tion of the ‘251ir-Bgt binding assay [8] at 37°C and 
20 nM a-Bgt finaf cont. Non-specific binding was 
determined by preincubation with cold cr-Bgt, 10m7 M, 
followed by r2’1-a-Bgt, and usually averaged 5%. 
2.3. Enzyme and protein assays 
ACHE activity was determined on homogenized 
and sonicated tissue by the method in ]9] using 
acetylthiocholine iodide (ACTC) as substrate. Non- 
specific cholinesterase (acylcholine acylhydrolase, 
EC 3 .l .l .S) was selectively inhibited [lo] with 
0.1 mM iso-OMPA (tetraisopropyl pyrophosphor- 
amide). Creatine kinase (CK, EC 2.7.3.2) activity was 
determined by the method in [ 111. Cell protein was 
determined by the method in [ 121 using bovine 
serum albumin as standard. 
2.4. RNA and protein synthesis 
[.5-3H]Uridine at 3 pCi/dish was added to cells for 
1 h to determine RNA synthesis. Incorporation of 
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radioactive leucine into protein was measured by 
adding 10 pCi/dish of L-[4,S-3H]leucine to cells in 
leucine-free media for 1 h. For each assay trichloro- 
acetic acid precipitates of cell homogenates were 
collected on glass filters. dissolved in protosol and a 
toluene-based fluor and counted in a liquid scintilla- 
tion counter [ 131. Non-specific binding of [3H] - 
uridine to cell homogenates was determined and 
subtracted from total counts. 
2.5. Drugs and isotopes 
Ouabain, obtained from Sigma Chemical Co., was 
dissolved in MEM and filtered sterilely into complete 
media. Actinomycin D, obtained from Calbiochem, 
was dissolved sterilely in distilled water and diluted to 
0.02 mg/ml final cont. in media. Carrier-free Na-“‘1 
(5 mCi, 17 Ci/mg), [3H]l eucinc (50 Ci/mmol) and 
[3H]uridine (25 Ci/mmol) were obtained from New 
England Nuclear. 
3. Results 
ACHR increased by 75% after 24 h and by 270% 
after 48 h incubation in 1 O-’ M ouabain (table 1). 
Protein synthesis was only slightly increased (14%), 
and total cell protein was unchanged over the same 
time interval (table 1). No significant changes in 
either cellular ACHE or in the amount of enzyme 
released into the medium were noted after 24 h in the 
drug. Cell ACHE activity was increased by 99% after 
48 h (table 2). There were no significant changes in 
cell or media CK activities (table 2). 
There were no changes in ACHR after 24 h or 
48 h in the presence of 10m6 M ouabain (table 1). 
However, protein synthesis, cell protein, and cellular 
ACHE activity increased by 33%, 12% and 42%, res- 
pectively (tables 1,2). 
Cytotoxicity was evident as early as 24 h after 
addition of lOA M ouabain. Myotubes were smaller 
than controls, and there was much floating cell debris. 
By 48 h, ACHR, protein synthesis and cell protein 
decreased by 27%, 85% and 36%, respectively (table 1). 
Large decreases in cell and media ACHE activity also 
occurred (table 2). There were many degenerating 
myotubes and much floating cell debris. 
At 1O-5 M, there was some flattening of myotubes, 
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Table 1 
Changes in ACHR, [3H]leucine incorporation, and cell 
protein in chick muscle cultures in response to ouabain 
ACHR [ jH] Leucine Cell 
incorporation protein 
02 
Control 170 i 24 136* 16 
24 
Control 203 f 8 
Ouabain 
lo-“ M 168i Bb - 
1O-5 M 355*32b - 
1O-6 M 201 + 28 - 
48 h 
Control 211 i 10 172i 10 
Ouabain 
1O-4 M 153 i 12b 25 + 1.5c 
10.’ M 783+45c 196 + 0.8” 
1O-6 M 197i 18 229 * 8.0b 
1.03 + 0.005 
1.16 i 0.075 
0.98 i 0.103” 
1.08 + 0.137 
1.13 + 0.035 
1.21 +_ 0.044 
0.78 + 0.078c 
1.17 3 0.163 
1.35 f 0.005b 
ap G 0.02,bp G 0.01, c p Q 0.001, statistically different 
from controls 
Day 8 pectoral muscle cultures were incubated for 24 h and 
48 h with 10e4 M, 10.’ M and low6 M ouabain. ACHR in 
fmol ‘2”1-a-BGT bound/dish; [3H]leucine incorporation into 
protein in cpm/dish X 1 03; cell protein in mg/dish. Means i SD, 
3 samples/value 
some floating cell debris was observed, and spontane- 
ous contractions were absent. At 1 0m6 M, the cells 
looked normal and spontaneous contractions were 
observed. 
[3H] Uridine incorporation was increased 3.8-fold 
by lo-’ M ouabain, and 13.8-fold by 5 X 1 0m6 M 
ouabain after 24 h (table 3). Myotubes appeared 
normal but spontaneous contractions were not 
observed at either concentration. 
Actinomycin D at 0.02 pg/dish blocked [3H]uridine 
incorporation in control and ouabain-treated cells 
without gross cytotoxic effects. Myotubes were intact 
and retained cross-striations. Actinomycin D abolished 
spontaneous contractions regardless of the presence 
or absence of ouabain. [3H]Uridine incorporation 
was 22% of untreated in controls, 3.3% of untreated 
at lO--’ M ouabain, and 0.6% of untreated at 
5 X 1 0e6 M ouabain (table 3). Higher actinomycin D 
levels caused extensive destruction of the myotubes. 
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Table 2 
Changes in enzyme activities in chick muscle cultures in response to ouabain 
02 
Control 
24 
Control 
Ouabain 
lo-“ M 
10-s M 
1O-6 M 
48h 
Control 
Ouabain 
1O-4 M 
lo-’ M 
1O-6 M 
ACHE 
Cell Media 
CK 
Cell Media 
19.5 2 6.6 _ 242 + 29 - 
30.2 +_ 4.9 125 * 23 500? 19 4.65 + 0.38 
7.2 * O.lc 23 + gb _ __ 
30.4 * 2.2 79 * 21 536 + 51 1.54 f 0.66b 
35.0 i 1.6 117+ 16 476 * 70 3.79 f 0.20a 
27.6 i 2.0 221+ 3 
4.9 f 0.7c 16i- 2c 
55.0 f 3.oc 283? 53 
39.1 f 3.2b 229 f 10 
a p G 0.02, b p < 0.01, ‘p < 0.001, statistically different from controls 
Day 8 pectoral muscle cultures incubated for 24 h and 48 h in 10m4 M, lo‘* M, 
10s6 M ouabain. ACHE in nmol ACTC hydrolyzed/min/dish; CK in pmol NADPH, 
formed/min/dish X lo-*. Means * SD, 3 samples/value 
Table 3 
RNA synthesis in chick muscle cultures in the presence of ouabain and 
actinomycin D 
Untreated OUA/C Actinomycin D ACT/U 
CL!! 
Control 12.7 f 6.3 - - _ 
24h 
Control 20.0 f 3.4 - 4.48 i 3.31 0.220a 
Ouabain 
10-s M 75.2 + 19.4 3.8a 2.46 + 0.44 0.033a 
5 x 1O-6 M 276.0 f 18.0 13.8a 1.58 + 0.68 0.006a 
a p G 0.05, statistically different from controls 
Pectoral muscle cultures, 8 days in vitro, incubated for 24 h with 10m5 M or 
5 X 1Om6 M ouabain and 0.04 pg/dish actinomycin D. Values expressed as incor- 
poration of [3H]uridine into RNA, cpm/dish X 10m3. Means i SD from triplicate 
dishes. OUA, ouabam treated;C, control;ACT, actinomycin D treated;U, untreated 
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4. Discussion 
The results demonstrate that ouabain increases 
ACHR levels, ACHE activity and [3H]uridine incor- 
poration into RNA of cultured muscle in a dose- 
dependent manner. The increases were accompanied 
by a modest increase in protein synthesis and the 
activity of a muscle specific enzyme, creatine kinase, 
did not increase at all. 
The increase in cellular but not media ACHE 
activity after ouabain treatment suggests that 
ouabain may have affected release of ACHE. ACHE 
is normally released in large quantities by chick muscle 
and nerve cultures 12,141. Its release can be blocked 
by verapamil [ 151, and has been reported to be 
affected by specific ionophores [ 161. 
The mechanism by which ouabain exerts the effects 
reported here is not known. The major known action 
of the drug is to inhibit the Na*/K’ ATPase and thus 
active Na’ extrusion, a~t~ollgll changes in ATP pools, 
adenyl cyclase, or cyclic nucleotides may also occur 
[17]. * 
Ouabain and other drugs affecting ACHE and 
ACHR levels have been observed to inhibit spontane- 
ous contractions of cultured muscle, supporting the 
idea that contractile activity per se may be a part of 
the system regulating muscle proteins. Evidence 
against this theory is that regulation of ACHE has 
been found in cultured nerve cells with at least one 
agent (acetyl-P-methylcholine) that acts upon muscle 
[14]. Ouabain also affects tissues other than muscle. 
It increases RNA, DNA and protein synthesis in 
cultured chick spinal neurons [ 18,191 and hemo- 
globin synthesis in Friend erythroleukemia mouse 
cells 1201. Ouabain decreases 35 S-methionine incor- 
poration into cultured rat lens protein [21], growth 
of HeLa cells [22], and RNA, DNA and protein syn- 
thesis in lymphocytes after mitogen activation [ 171. 
There are several similarities between the actions 
of ouabain on cultured muscle and the effect of 
denervation on muscle in situ. Denervation of 
skeletal muscle increases ACHR levels and sensitivity 
to acetylcl~oline in all species studied 1231, ACHE 
levels in at least the chicken and rabbit [24,25] and 
RNA synthesis in the frog [26]. Ouabain depolarizes 
skeletal muscle to the same extent as denervation 
[27] and does not produce any further depolariza- 
tion of denervated muscle [28,29]. 
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A possible basis for these actions of ouabain is 
through alteration of ionic ~on~eittrations and fluxes. 
Serum has been shown [30] to regulate DNA syn- 
thesis in fibroblasts through an action on the Na’/K’ 
pump by altering the availability of Na* and K’. 
Additional evidence suggesting that ion regulation is 
involved in muscle development are the findings that 
agents such as tetrodotoxill, lidocaine, and D-600 
increase ACHR, ACHE and turnover of myosin heavy 
chains in chick muscle cultures [4,5,3 1,321. Intra- 
cellular K’ concentrations have been shown to 
regulate protein, RNA and DNA synthesis of cultured 
human fibroblasts 1331. 
General stinlulatioli in RNA synthesis is suggested 
by the large increase in [3H]uridine incorporation by 
ouabain that can be blocked by actinomycin D. The 
possibility that some of the increase could be due to 
altered nucleotide pool sizes is being investigated. 
Induction ofmRNA sy~lthesisispossible, but whether 
increases in ACHR and ACHE stinlulated by ouabain 
can also be blocked by actinomycin D is not known. 
Actinomycin D blocks increases in ACHR stimulated 
by tetrodotoxin, possibly indicating specific induc- 
tion of muscle genes [S], but does not block increases 
in ACHE activity stimulated by a~ety~-~-l?letliyl- 
choline [34]. 
The specificity of ouabain’s effect on ACHR and 
to a lesser extent on ACHE and general protein syn- 
thesis may be the result of either induction of specific 
messages or regulation of post-transcriptional events. 
Cell-free experiIilei?ts indicate that specific mRNAs 
are preferentially translated depending upon the 
Na’ and K’concentrations [35%37]. 
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